Stay updated on Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision tag on the page updated to v3.6.5, signaling a newer version of the page or template. No study details or visible content are affected by this update.
    Difference
    0.1%
    Check dated 2026-08-10T13:48:28.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision: v3.6.4 is now displayed on the page, replacing the previous Revision: v3.6.3. This indicates a minor platform update with no changes to the study details or visible content.
    Difference
    0.1%
    Check dated 2026-07-27T06:19:21.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    40 days ago
    Change Detected
    Summary
    The page now displays an updated revision tag (Revision: v3.6.3), replacing the previous Revision: v3.6.2.
    Difference
    0.1%
    Check dated 2026-07-05T15:37:55.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    A new revision tag (v3.6.2) was added and the previous tag (v3.6.0) removed, indicating a platform software update.
    Difference
    0.1%
    Check dated 2026-06-28T08:43:01.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Recruitment status now shows no more participants; new user guidance sections were added, and the Intervention/Treatment header formatting was updated to reflect the current structure of the study details.
    Difference
    0.4%
    Check dated 2026-06-14T05:14:17.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    The study record shows a new revision (v3.5.5) replacing the previous revision (v3.5.4), indicating an updated page version rather than new study data.
    Difference
    0.1%
    Check dated 2026-06-07T00:24:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Bevacizumab in Recurrent GBM Clinical Trial page.